Celentyx

company

About

Celentyx is a CRO offering bespoke assay services in human immunology, including immuno-oncology, autoimmunity & inflammation, fibrosis.

  • 11 - 50

Details

Last Funding Type
Seed
Industries
Association,Biotechnology
Founded date
Jan 1, 2007
Number Of Employee
11 - 50
Operating Status
Active

Celentyx Ltd is a CRO offering bespoke assay services in human immunology, including immuno-oncology, autoimmunity & inflammation, fibrosis and neuroinflammation.
Drawing on the World-leading expertise of Celentyx personnel, along with our close association with the MRC Centre for Immune Regulation and the Centre for Translational Inflammation Research enables the human immune system in health and disease to be investigated at the highest levels of resolution.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Celentyx has raised a total of — in funding over 2 rounds. Their latest funding was raised on Dec 12, 2007 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 12, 2007 Seed 1 Mercia Fund Managers Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Celentyx is funded by 1 investors. Mercia Fund Managers are the most recent investors.
Investor Name Lead Investor Funding Round
Mercia Fund Managers Yes Seed